ITH response to CPS decision to charge with offences under Section 3 and 33 Health and Safety at Work Act and Section 64 and 67 of the Medicines Act. “As founders of ITH we have every sympathy for all the families affected, regardless of the cause. However, we are disappointed by the decision to charge…
DetailsDetails of ITH Pharma opening hours over the Easter Period for 2018
DetailsSince our launch back in 2008 our reputation has enabled us to continue supplying more NHS Trusts across the UK. ITH Pharma has now extended contracts on both the Berkshire and Scottish frameworks for a further 12 months.
DetailsDetails of ITH Pharma opening hours over the Christmas and New Year Period for 2017 – 2018
DetailsSince its launch back in April the PN online ordering system has gone on to become a massive success with our customers.
DetailsITH has been awarded the East Midlands chemotherapy tender for the next 2, potentially 3 years. The tender allows ITH Pharma to supply chemotherapy products to up to 18 Hospitals across 12 NHS Trusts covered by the East Midlands group.
DetailsITH Pharma made a successful return to the Clinical Pharmacy Congress 2017 at London Excel on the 12th and 13th May with our largest ever stand. The exhibition provided a chance for us to connect with a large number of our existing customers to discuss present and future plans for the business. Chief amongst the…
DetailsOver the last year ITH Pharma has witnessed continued growth through all sectors of business and a consistent programme of recruitment. This has enabled us to recruit vital members of staff who we believe will be pivotal in moving our business forward over the coming months and years. In the Quality department Richard Bateman has…
DetailsWe will be returning to The Clinical Pharmacy Congress (CPC) at the ExCeL London, stand C30 on the 12th and 13th May. This will be the largest gathering of the clinical pharmacy profession held in the UK. This year we have invested more in increased floor space, to ensure we can engage with a wider…
Details
